Eric Ashman

4.1k total citations · 4 hit papers
15 papers, 2.8k citations indexed

About

Eric Ashman is a scholar working on Psychiatry and Mental health, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Eric Ashman has authored 15 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Neurology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Eric Ashman's work include Pharmacological Effects and Toxicity Studies (5 papers), Epilepsy research and treatment (4 papers) and Traumatic Brain Injury and Neurovascular Disturbances (4 papers). Eric Ashman is often cited by papers focused on Pharmacological Effects and Toxicity Studies (5 papers), Epilepsy research and treatment (4 papers) and Traumatic Brain Injury and Neurovascular Disturbances (4 papers). Eric Ashman collaborates with scholars based in United States, Somalia and Belgium. Eric Ashman's co-authors include Gary Gronseth, Charles E. Argoff, F. G. Freitag, David W. Dodick, Stephen D. Silberstein, Stuart A. Yablon, Melissa J. Armstrong, Risa Nakase‐Richardson, John Whyte and Nicholas D. Schiff and has published in prestigious journals such as Neurology, Critical Care Medicine and Archives of Physical Medicine and Rehabilitation.

In The Last Decade

Eric Ashman

14 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults

2012 617 citations Stephen D. Silberstein, F. G. Freitag et al. Neurology profile →
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED]

2016 436 citations David M. Simpson, Mark Hallett et al. Neurology profile →
Practice guideline update recommendations summary: Disorders of consciousness

2018 420 citations Joseph T. Giacino, Douglas I. Katz et al. Neurology profile →
Comprehensive systematic review update summary: Disorders of consciousness

2018 310 citations Joseph T. Giacino, Douglas I. Katz et al. Neurology profile →

Peers

Countries citing papers authored by Eric Ashman

Since Specialization

Citations

This map shows the geographic impact of Eric Ashman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Ashman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Ashman more than expected).

Fields of papers citing papers by Eric Ashman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Ashman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Ashman. The network helps show where Eric Ashman may publish in the future.

Co-authorship network of co-authors of Eric Ashman

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Ashman. A scholar is included among the top collaborators of Eric Ashman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Ashman. Eric Ashman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Practice guideline update recommendations summary: Disorders of consciousness breakdown → 2018 ·Neurology ·Joseph T. Giacino, Douglas I. Katz, Nicholas D. Schiff, John Whyte, Eric Ashman, Stephen Ashwal, Richard L. Barbano, Flora M. Hammond, Steven Laureys, Geoffrey Ling, Risa Nakase‐Richardson, Ronald T. Seel, Stuart A. Yablon, Thomas S.D. Getchius, Gary Gronseth, Melissa J. Armstrong	420
2	Comprehensive Systematic Review Update Summary: Disorders of Consciousness 2018 ·Archives of Physical Medicine and Rehabilitation ·Joseph T. Giacino, Douglas I. Katz, Nicholas D. Schiff, John Whyte, Eric Ashman, Stephen Ashwal, Richard L. Barbano, Flora M. Hammond, Steven Laureys, Geoffrey Ling, Risa Nakase‐Richardson, Ronald T. Seel, Stuart A. Yablon, Thomas S.D. Getchius, Gary Gronseth, Melissa J. Armstrong	143
3	Practice Guideline Update Recommendations Summary: Disorders of Consciousness 2018 ·Archives of Physical Medicine and Rehabilitation ·Joseph T. Giacino, Douglas I. Katz, Nicholas D. Schiff, John Whyte, Eric Ashman, Stephen Ashwal, Richard L. Barbano, Flora M. Hammond, Steven Laureys, Geoffrey Ling, Risa Nakase‐Richardson, Ronald T. Seel, Stuart A. Yablon, Thomas S.D. Getchius, Gary Gronseth, Melissa J. Armstrong	187
4	Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy 2018 ·Epiliepsy currents ·Andrés M. Kanner, Eric Ashman, David Gloss, Cynthia L. Harden, Blaise F. D. Bourgeois, Jocelyn F. Bautista, Bassel Abou‐Khalil, Evren Burakgazi-Dalkilic, (unknown), John M. Stern, Deborah Hirtz, Mark Nespeca, Barry E. Gidal, Edward Faught, Jacqueline A. French	48
5	Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy 2018 ·Neurology ·Andrés M. Kanner, Eric Ashman, David Gloss, Cynthia L. Harden, Blaise F. D. Bourgeois, Jocelyn F. Bautista, Bassel Abou‐Khalil, Evren Burakgazi-Dalkilic, (unknown), John M. Stern, Deborah Hirtz, Mark Nespeca, Barry E. Gidal, Edward Faught, Jacqueline A. French	84
6	Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy 2018 ·Neurology ·Andrés M. Kanner, Eric Ashman, David Gloss, Cynthia L. Harden, Blaise F. D. Bourgeois, Jocelyn F. Bautista, Bassel Abou‐Khalil, Evren Burakgazi-Dalkilic, (unknown), John M. Stern, Deborah Hirtz, Mark Nespeca, Barry E. Gidal, Edward Faught, Jacqueline A. French	135
7	Comprehensive systematic review update summary: Disorders of consciousness breakdown → 2018 ·Neurology ·Joseph T. Giacino, Douglas I. Katz, Nicholas D. Schiff, John Whyte, Eric Ashman, Stephen Ashwal, Richard L. Barbano, Flora M. Hammond, Steven Laureys, Geoffrey Ling, Risa Nakase‐Richardson, Ronald T. Seel, Stuart A. Yablon, Thomas S.D. Getchius, Gary Gronseth, Melissa J. Armstrong	310
8	801: ACUTE ENCEPHALOPATHY? CHECK THE SPICE RACK! 2018 ·Critical Care Medicine ·Anita Shallal, (unknown), (unknown), Eric Ashman	0
9	Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy 2018 ·Epiliepsy currents ·Andrés M. Kanner, Eric Ashman, David Gloss, Cynthia L. Harden, Blaise F. D. Bourgeois, Jocelyn F. Bautista, Bassel Abou‐Khalil, Evren Burakgazi-Dalkilic, (unknown), John M. Stern, Deborah Hirtz, Mark Nespeca, Barry E. Gidal, Edward Faught, Jacqueline A. French	45
10	Practice guideline: Cervical and ocular vestibular evoked myogenic potential testing 2017 ·Neurology ·Terry D. Fife, James G. Colebatch, Kevin A. Kerber, Krister Brantberg, Michael Strupp, Hyung Lee, Mark F. Walker, Eric Ashman, (unknown), Brian C. Callaghan, David Gloss	88
11	Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED] breakdown → 2016 ·Neurology ·David M. Simpson, Mark Hallett, Eric Ashman, Cynthia Comella, Mark W. Green, Gary Gronseth, Melissa J. Armstrong, David Gloss, Sonja Potrebic, Joseph Jankovic, Barbara Karp, Markus Naumann, Yuen T. So, Stuart A. Yablon	436
12	Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults breakdown → 2012 ·Neurology ·Stephen D. Silberstein, (unknown), F. G. Freitag, David W. Dodick, Charles E. Argoff, Eric Ashman	617
13	Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: [RETIRED] 2012 ·Neurology ·(unknown), Stephen D. Silberstein, F. G. Freitag, David W. Dodick, Charles E. Argoff, Eric Ashman	231
14	Practice parameter: The usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review) 2000 ·Neurology ·Gary Gronseth, Eric Ashman	77
15	PRACTICE PARAMETER: THE USEFULNESS OF EVOKED POTENTIALS IN IDENTIFYING CLINICALLY SILENT LESIONS IN PATIENTS WITH SUSPECTED MULTIPLE SCLEROSIS 2000 ·Gary Gronseth, Eric Ashman	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact